Abstract
Background and Aims: The left ventricular ejection fraction(LVEF) is key to prognosis in dilated cardiomyopathy(DCM). Circulating microRNAs have emerged as reliable biomarkers for cardiovascular diseases. Improved tools for better determination of DCM-EF categorization, to identify high-risk patients are needed. Our aim is to assess microRNAs a useful marker to categorize DCM patients based on their EF.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
